EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins
Leah Fitzsimmons(University of Birmingham), Gemma L. Kelly(The University of Melbourne)
Cited by 61
Related Papers
Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in <i>p53</i>
|Genes & Development|2014|169
Coordinated repression of BIM and PUMA by Epstein–Barr virus latent genes maintains the survival of Burkitt lymphoma cells
|Cell Death and Differentiation|2017|30